Copyright Reports & Markets. All rights reserved.

Global Imatinib Mesylate Market Insights and Forecast to 2026

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Imatinib Mesylate Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Imatinib Mesylate Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Imatinib Mesylate Market Size Growth Rate by Type
    • 1.4.2 99% Purity
    • 1.4.3 98% Purity
    • 1.4.4 Other
  • 1.5 Market by Application
    • 1.5.1 Global Imatinib Mesylate Market Size Growth Rate by Application
    • 1.5.2 CML
    • 1.5.3 GIST
    • 1.5.4 Other
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Imatinib Mesylate Market Size, Estimates and Forecasts
    • 2.1.1 Global Imatinib Mesylate Revenue 2015-2026
    • 2.1.2 Global Imatinib Mesylate Sales 2015-2026
  • 2.2 Global Imatinib Mesylate, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Imatinib Mesylate Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Imatinib Mesylate Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Imatinib Mesylate Competitor Landscape by Players

  • 3.1 Imatinib Mesylate Sales by Manufacturers
    • 3.1.1 Imatinib Mesylate Sales by Manufacturers (2015-2020)
    • 3.1.2 Imatinib Mesylate Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Imatinib Mesylate Revenue by Manufacturers
    • 3.2.1 Imatinib Mesylate Revenue by Manufacturers (2015-2020)
    • 3.2.2 Imatinib Mesylate Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Imatinib Mesylate Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Imatinib Mesylate Revenue in 2019
    • 3.2.5 Global Imatinib Mesylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Imatinib Mesylate Price by Manufacturers
  • 3.4 Imatinib Mesylate Manufacturing Base Distribution, Product Types
    • 3.4.1 Imatinib Mesylate Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Imatinib Mesylate Product Type
    • 3.4.3 Date of International Manufacturers Enter into Imatinib Mesylate Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Imatinib Mesylate Market Size by Type (2015-2020)
    • 4.1.1 Global Imatinib Mesylate Sales by Type (2015-2020)
    • 4.1.2 Global Imatinib Mesylate Revenue by Type (2015-2020)
    • 4.1.3 Imatinib Mesylate Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Imatinib Mesylate Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Imatinib Mesylate Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Imatinib Mesylate Revenue Forecast by Type (2021-2026)
    • 4.2.3 Imatinib Mesylate Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Imatinib Mesylate Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Imatinib Mesylate Market Size by Application (2015-2020)
    • 5.1.1 Global Imatinib Mesylate Sales by Application (2015-2020)
    • 5.1.2 Global Imatinib Mesylate Revenue by Application (2015-2020)
    • 5.1.3 Imatinib Mesylate Price by Application (2015-2020)
  • 5.2 Imatinib Mesylate Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Imatinib Mesylate Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Imatinib Mesylate Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Imatinib Mesylate Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Imatinib Mesylate by Country
    • 6.1.1 North America Imatinib Mesylate Sales by Country
    • 6.1.2 North America Imatinib Mesylate Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Imatinib Mesylate Market Facts & Figures by Type
  • 6.3 North America Imatinib Mesylate Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Imatinib Mesylate by Country
    • 7.1.1 Europe Imatinib Mesylate Sales by Country
    • 7.1.2 Europe Imatinib Mesylate Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Imatinib Mesylate Market Facts & Figures by Type
  • 7.3 Europe Imatinib Mesylate Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Imatinib Mesylate by Region
    • 8.1.1 Asia Pacific Imatinib Mesylate Sales by Region
    • 8.1.2 Asia Pacific Imatinib Mesylate Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Imatinib Mesylate Market Facts & Figures by Type
  • 8.3 Asia Pacific Imatinib Mesylate Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Imatinib Mesylate by Country
    • 9.1.1 Latin America Imatinib Mesylate Sales by Country
    • 9.1.2 Latin America Imatinib Mesylate Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Imatinib Mesylate Market Facts & Figures by Type
  • 9.3 Central & South America Imatinib Mesylate Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Imatinib Mesylate by Country
    • 10.1.1 Middle East and Africa Imatinib Mesylate Sales by Country
    • 10.1.2 Middle East and Africa Imatinib Mesylate Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Imatinib Mesylate Market Facts & Figures by Type
  • 10.3 Middle East and Africa Imatinib Mesylate Market Facts & Figures by Application

11 Company Profiles

  • 11.1 GLEEVEC
    • 11.1.1 GLEEVEC Corporation Information
    • 11.1.2 GLEEVEC Description and Business Overview
    • 11.1.3 GLEEVEC Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GLEEVEC Imatinib Mesylate Products Offered
    • 11.1.5 GLEEVEC Related Developments
  • 11.2 Cayman Chemical
    • 11.2.1 Cayman Chemical Corporation Information
    • 11.2.2 Cayman Chemical Description and Business Overview
    • 11.2.3 Cayman Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Cayman Chemical Imatinib Mesylate Products Offered
    • 11.2.5 Cayman Chemical Related Developments
  • 11.3 Sichuan Xieli
    • 11.3.1 Sichuan Xieli Corporation Information
    • 11.3.2 Sichuan Xieli Description and Business Overview
    • 11.3.3 Sichuan Xieli Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Sichuan Xieli Imatinib Mesylate Products Offered
    • 11.3.5 Sichuan Xieli Related Developments
  • 11.4 Nanjing Kaihua Chemical
    • 11.4.1 Nanjing Kaihua Chemical Corporation Information
    • 11.4.2 Nanjing Kaihua Chemical Description and Business Overview
    • 11.4.3 Nanjing Kaihua Chemical Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Nanjing Kaihua Chemical Imatinib Mesylate Products Offered
    • 11.4.5 Nanjing Kaihua Chemical Related Developments
  • 11.5 Zhengda Tianqing
    • 11.5.1 Zhengda Tianqing Corporation Information
    • 11.5.2 Zhengda Tianqing Description and Business Overview
    • 11.5.3 Zhengda Tianqing Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Zhengda Tianqing Imatinib Mesylate Products Offered
    • 11.5.5 Zhengda Tianqing Related Developments
  • 11.1 GLEEVEC
    • 11.1.1 GLEEVEC Corporation Information
    • 11.1.2 GLEEVEC Description and Business Overview
    • 11.1.3 GLEEVEC Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 GLEEVEC Imatinib Mesylate Products Offered
    • 11.1.5 GLEEVEC Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Imatinib Mesylate Market Estimates and Projections by Region
    • 12.1.1 Global Imatinib Mesylate Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Imatinib Mesylate Revenue Forecast by Regions 2021-2026
  • 12.2 North America Imatinib Mesylate Market Size Forecast (2021-2026)
    • 12.2.1 North America: Imatinib Mesylate Sales Forecast (2021-2026)
    • 12.2.2 North America: Imatinib Mesylate Revenue Forecast (2021-2026)
    • 12.2.3 North America: Imatinib Mesylate Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Imatinib Mesylate Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Imatinib Mesylate Sales Forecast (2021-2026)
    • 12.3.2 Europe: Imatinib Mesylate Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Imatinib Mesylate Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Imatinib Mesylate Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Imatinib Mesylate Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Imatinib Mesylate Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Imatinib Mesylate Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Imatinib Mesylate Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Imatinib Mesylate Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Imatinib Mesylate Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Imatinib Mesylate Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Imatinib Mesylate Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Imatinib Mesylate Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Imatinib Mesylate Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Imatinib Mesylate Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Imatinib Mesylate Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Imatinib Mesylate Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Imatinib Mesylate market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Imatinib Mesylate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Imatinib Mesylate market is segmented into
    99% Purity
    98% Purity
    Other

    Segment by Application, the Imatinib Mesylate market is segmented into
    CML
    GIST
    Other

    Regional and Country-level Analysis
    The Imatinib Mesylate market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Imatinib Mesylate market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Imatinib Mesylate Market Share Analysis
    Imatinib Mesylate market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Imatinib Mesylate business, the date to enter into the Imatinib Mesylate market, Imatinib Mesylate product introduction, recent developments, etc.

    The major vendors covered:
    GLEEVEC
    Cayman Chemical
    Sichuan Xieli
    Nanjing Kaihua Chemical
    Zhengda Tianqing
    ...

    Buy now